About US
BB-Bridge, Inc. (BB-Bridge) is established as a research consulting firm in the field of life and medical science. We support our clients promote research and development (R&D) and promote their business smoothly. BB-Bridge drives its name from “Bench to Bedside”, which means to promptly apply the R&D result to clinical stages, and we provide lots of services to promote your business.
Founder | Satoshi Banba |
---|---|
Founded | October 1st, 2014 |
Capital | 3 million yen |
Address | #101 CLIO Hiratsuka 7bankan, 6-20, Miyanomae, Hiratsuka-shi, Kanagawa-ken |
TEL | 81-463-73-6612 |
Affiliated Organizations |
JBA:Japan Bioindustry Association Chem-Bio Informatics Association Health Technology Assessment international (HTAi) |
Technology and Market Research Report
BB-Bridge publish reports on a hot medical technology and markets specializing in life and medical science.
Title | Publish | Price |
---|---|---|
Development of Pharmaceuticals and Diagnosis using Microbiome technology | Nov, 2014 | 100,000 yen |
Current Status and Future Prospect of Gene Therapy | Nov, 2014 | 180,000 yen |
Current Status and Future Prospect of Cell Therapy | Nov, 2014 | 180,000 yen |
Personal Testing Services for Prevention medicine | Jan, 2015 | 100,000 yen |
Current Status and Future Prospect of Biopharma Manufacturing Industry | Apr, 2015 | 180,000 yen |
Development of Pharmaceuticals and Diagnosis using Health Technology Assessment | Jun, 2015 | 180,000 yen |
* All reports are written by Japanese
Custom Research and Consulting
BB-Bridge provides research and consulting services according to clients’ needs. Our advantage is a wealth of knowledge and experience in biotechnology-based pharmaceuticals, e.g. gene medicine, nucleic acid medicine, antibody drug, peptide drug and cell drug, next-generation testing techniques such as molecular imaging, genetic testing and companion diagnosis, other combination products and medical economic evaluation.
Subject | Target Area | Period of the Project |
---|---|---|
Research on the diagnostic technology of brain image and its marketability. | Domestic | 2 weeks |
Research on the technology for new drug development concepts. | Worldwide | 1 month |
Research on the new administration technology of biopharmaceuticals. | Worldwide | 3 weeks |
Research on R&D trends of the new antibody drugs. | Worldwide | 3 weeks |
Research on the surrounding industry of biopharmaceuticals. | Worldwide | 2 months |
Research on the development of recombinant proteins. | Worldwide | 6 weeks |
Basic research on the development and manufacture of biopharmaceuticals in China. | china | 2 weeks |